Critical Limb Ischemia

Related by string. critical limb ischemia * criti cal . CRITICAL . criticals . critical : Critical Care Medicine . Critical Condition After . garnered critical acclaim . garnering critical acclaim / limber . Limbs . Limber : loose limbed . snapped tree limbs . fallen tree limbs / ischemia : emergent cardiac ischemia . hypoxia ischemia . myocardial ischemia * Critical Limb Ischemia CLI *

Related by context. All words. (Click for frequent words.) 73 Overactive Bladder 72 Critical Limb Ischemia CLI 71 Peripheral Artery Disease 71 Diabetic Foot Ulcer 70 Ischemic 69 Benign Prostatic Hyperplasia 69 Diabetic Retinopathy 69 Advanced Melanoma 69 Renal Cell Carcinoma 69 Rheumatoid Arthritis Patients 69 Efficacy Trial 69 Meets Primary Endpoint 69 Pulmonary Arterial Hypertension 69 Patients Treated With 69 Phase III Clinical Trial 69 Chronic Sinusitis 69 Hepatic Encephalopathy 69 Dupuytren Contracture 69 Diabetic Foot Ulcers 68 Clinical Trial Results 68 Benign Prostatic Hyperplasia BPH 68 Peripheral Arterial Disease 68 Pivotal Trial 68 Peripheral Arterial 68 ST Elevation Myocardial 68 Non Invasive Treatment 68 Oral Mucositis 67 Improves Outcomes 67 Lupus Nephritis 67 Successfully Treated 67 FDA Approvals 67 Diastolic Heart Failure 67 Spinal Fusion 67 Acute Ischemic Stroke 67 Hormone Refractory Prostate Cancer 67 Treating Chronic 67 Metastatic Prostate Cancer 67 Improves Survival 67 Phase 2b Clinical Trial 67 Hepatocellular Carcinoma 67 Investigational Treatment 67 Pivotal Clinical Trial 67 Mucositis 67 Heart Failure Patients 67 overactive bladder syndrome 67 Phase III Trial 67 Initiate Clinical Trial 67 Relapsing Remitting Multiple Sclerosis 67 Adjunctive 67 Severe Sepsis 67 Malignant Melanoma 66 Thrombus 66 Patients Receiving 66 Chronic Heart Failure 66 Endometrial Cancer 66 Electrical Stimulation 66 Metastatic Melanoma 66 Phase 2b Trial 66 Prospective Randomized 66 Diabetic Neuropathy 66 Non Alcoholic Fatty 66 Demonstrates Positive 66 Chronic Myeloid Leukemia 66 Acute Heart Failure 66 Renal Artery 66 Diabetic Patients 66 Valve Replacement 66 Mitral Regurgitation 66 Diabetic Nephropathy 66 Adjuvant Treatment 66 Successfully Treats 66 Files IND 66 Refractory Angina 66 IND Application 66 Treatment Reduces 66 Peptic Ulcer 66 ACE Inhibitors 66 Peripheral Vascular Disease 66 Improve Survival 66 Prolongs Survival 66 Thromboembolism 66 Myelofibrosis 65 Knee Osteoarthritis 65 Catheter Associated 65 Breast Cancer Recurrence 65 dual endothelin receptor antagonist 65 Pivotal Phase III 65 Embolization 65 Diabetic Ulcers 65 Frozen Shoulder Syndrome 65 Disease Progression 65 Prophylactic Treatment 65 Gastroesophageal Reflux Disease 65 Slow Progression 65 Malignant Glioma 65 Tyrosine Kinase Inhibitor 65 Diabetic Macular Edema 65 Atopic Dermatitis 65 occlusion CRVO 65 Patient Enrollment 65 Follicular Lymphoma 65 Fungal Infections 65 Coronary Artery Bypass Graft 65 Completes Enrollment 65 Pivotal Study 65 Liver Failure 65 Stem Cell Treatment 65 Hypotension 65 Juvenile Idiopathic Arthritis 65 Urinary Tract Infections 65 Phase IIa Clinical Trial 65 Rheumatoid Arthritis RA 65 Pivotal Phase 65 Oral Fingolimod 65 Clinical Trial Evaluating 65 Risk Stratification 65 Occlusion 65 Allergic Rhinitis 65 Patients Undergoing 65 Post Operative 65 Iron Overload 65 Renal Cancer 65 Drug Eluting 65 Atypical Hemolytic Uremic Syndrome 65 Drug Candidate 65 Ischemic Stroke 65 Adjunctive Therapy 65 Hypercholesterolemia 65 Phase III Pivotal 65 Pediatric Patients 65 MR Angiography 65 Infarct 65 Systemic Sclerosis 65 Shows Promise Against 65 Gets FDA Clearance 65 Unresectable 64 Immunosuppressant 64 Fracture Risk 64 Initiates Clinical Trial 64 Metastatic Colorectal Cancer 64 Acute Renal Failure 64 JAK Inhibitor 64 Stenosis 64 Initiates Phase II 64 Phase IIb Clinical Trial 64 Resistant Hypertension 64 Completes Patient Enrollment 64 Occlusive Disease 64 Clinical Outcome 64 Catheter Ablation 64 Bone Metastases 64 Safinamide 64 Coronary Arteries 64 Myoblast 64 Neovascular Age Related Macular 64 Reduces Mortality 64 Progenitor Cells 64 Reflux Disease 64 Less Invasive 64 Advanced Colorectal Cancer 64 Chronic Hepatitis B 64 Beta Blocker 64 NDA Submission 64 Ischemia 64 Osteoporotic 64 Surgical Procedures 64 Enlarged Prostate 64 Myelodysplastic Syndrome MDS 64 Renal Impairment 64 Premature Infants 64 Immunosuppression 64 Complicated Skin 64 Postmenopausal Osteoporosis 64 Iron Deficiency 64 Thromboembolic 64 Replacement Therapy 64 Intravascular 64 Patients Treated 64 Pivotal Trials 64 Intracerebral Hemorrhage 64 Growth Hormone Deficiency 64 Initiates Enrollment 64 Left Ventricular 64 Metabolic Disorder 64 Infarction 64 Myocardial Ischemia 64 Anticoagulants 64 Regenerative Cells 64 Brain Metastases 64 Heart Transplant Recipients 64 HeFH 64 Urinary Incontinence 64 Serious Infections 64 Slows Progression 64 Teriparatide 64 Shows Promising 64 Neuropathic 64 Lung Injury 64 Phase IIb Trial 64 Mouse Model 64 Transdermal Patch 64 metastatic neuroendocrine tumors 64 Methylnaltrexone 64 Neuroprotective Effects 64 Myelodysplastic Syndromes 64 Lowers Risk 64 Therapy Reduces 64 Relapsed Multiple Myeloma 64 Asthma COPD 64 biliary tract cancer 64 Node Positive 64 Acute Decompensated Heart Failure 64 Physician Insights 64 Myelodysplastic Syndrome 64 Predict Risk 64 Chronic Myelogenous Leukemia 64 FDA Okays 63 Migraine Headaches 63 Surgical Treatment 63 Gastric Cancer 63 Transcatheter 63 Skeletal Muscle 63 Fondaparinux 63 Breast Cancer Treatment 63 Fabry Disease 63 Sustained Reduction 63 Balloon Kyphoplasty 63 Bivalirudin 63 ORLive Presents 63 Renal Failure 63 Drug Shows Promise 63 Total Knee Arthroplasty 63 Lung Cancer Patients 63 Pulmonary Artery 63 NAVISTAR R 63 Degenerative Disc Disease 63 Irritable Bowel Syndrome IBS 63 Neoplasms 63 Hypertrophic 63 acute peripheral arterial 63 Proves Effective 63 Relapsing Multiple Sclerosis 63 Pooled Analysis 63 Naive Patients 63 B Cell Malignancies 63 Psoriatic Arthritis 63 Cardiotoxicity 63 Liver Metastases 63 Cell Lymphoma 63 Drug Prevents 63 Carotid Stenting 63 Antitumor Activity 63 HER2 Positive Breast Cancer 63 Angioedema 63 Delayed Graft Function 63 Bladder Cancer 63 Achieves Primary Endpoint 63 Squamous Cell Carcinoma 63 Diamondback #deg 63 Abciximab 63 Chronic Lymphocytic Leukemia 63 Insulin Delivery 63 Soft Tissue Sarcoma 63 Corneal Transplant 63 eosinophilic asthma 63 II Clinical Trial 63 Overactive Bladder OAB 63 Hyperparathyroidism 63 Endothelial 63 Enrolling Patients 63 Aliskiren 63 Placebo Controlled Trial 63 Improved Survival 63 Relapsed Refractory 63 Cutaneous T 63 Schizophrenia Treatment 63 Insulin Therapy 63 Rheumatoid 63 Prospective Multicenter 63 Recurrent Breast Cancer 63 Esophageal 63 Meningiomas 63 PAOD 63 First Patient Enrolled 63 Dupuytren Disease 63 acetonide FA 63 Septic Shock 63 venous reflux 63 Blood Pressure Drug 63 Liver Injury 63 superficial femoral 63 Symptom Relief 63 HuMax EGFr 63 Hypertensive Patients 63 Chemoradiation 63 Thrombotic 63 Kepivance 63 Chronic Renal Failure 63 Degarelix 63 Initiates Clinical 63 Receives Orphan Drug Designation 63 Interferon Beta 63 venous stasis ulcers 63 Microplasmin 63 Effectively Treats 63 Secondary Hyperparathyroidism 63 postoperative atrial fibrillation 63 Rheumatoid Arthritis Drug 63 Stakeholder Opinions 63 Aortic Valve Replacement 63 Nonsurgical 63 Randomized Clinical Trial 63 Clinical Relevance 63 Spinal Disc 63 Onychomycosis 63 Newly Diagnosed Multiple Myeloma 63 FDA Clears 63 atypical Hemolytic Uremic Syndrome 63 critical limb ischemia 63 Treatable 63 Glatiramer Acetate 63 Cholesterol Lowering Drug 63 Randomized Phase 63 Total Knee Replacement 63 Patients Suffering 63 Beta Blockers 63 Minimally Invasive Procedure 63 Microalbuminuria 63 Appears Safe 63 Systemic Lupus Erythematosus SLE 63 Combo Therapy 63 Interferon Gamma 63 Initiate Phase 63 Radiofrequency Ablation RFA 63 Lung Cancer Trial 63 FDA Approves Drug 63 Aneurysm Repair 63 Hyperuricemia 62 Chronic Prostatitis 62 Clostridium difficile Infection 62 Nonalcoholic Fatty Liver Disease 62 Hematopoietic 62 Sustained Efficacy 62 Bone Fracture 62 Atherosclerotic 62 Bipolar Depression 62 Genital Herpes 62 Golimumab 62 Long Term Efficacy 62 Carotid 62 Phase 2a Trial 62 Disease Modifying 62 Endovascular Graft 62 induced macular edema 62 Minimally Invasive Treatment 62 Chemotherapy Induced 62 Allogeneic 62 intermittent claudication 62 Acute Coronary Syndromes 62 Cervical Dystonia 62 Anterior Cruciate Ligament Reconstruction 62 Autoimmune Disease 62 Cognitive Impairment 62 Chemotherapy induced 62 EVIZON TM 62 Varicose Veins 62 Hemorrhagic Stroke 62 Balloon Angioplasty 62 Esophagitis 62 CT Angiography 62 Vitrectomy 62 Lymphoid 62 Gout Drug 62 Treatment Resistant 62 Elderly Patients 62 Urethral 62 Embolic Protection Device 62 Arteriovenous 62 Kidney Function 62 Venous Thromboembolism 62 Transplant Rejection 62 Analytical Tool 62 Metastases 62 Nilotinib 62 Vascular Grafts 62 Severe Primary IGFD 62 Tyrosine Kinase Inhibitors 62 Ischaemic 62 Acute Myocardial Infarction 62 Previously Treated 62 Percutaneous Tibial Nerve Stimulation 62 Multicenter Randomized 62 Hepatocellular Carcinoma HCC 62 Intravitreal 62 Treatment Outcome 62 Insulin Resistance 62 Etanercept 62 Arrhythmias 62 Prostate Cancer Vaccine 62 Innate Immune 62 Gum Disease 62 Bronchiectasis 62 Combination Treatment 62 complement inhibitor eculizumab 62 Neurostimulation 62 oxypurinol 62 Lung Cancer Drug 62 Inflammatory Diseases 62 Stress Urinary Incontinence 62 giant cell arteritis 62 Intracranial 62 Effective Treatments 62 Phase 2a Clinical Trial 62 Vertebral Compression Fractures 62 Severe Asthma 62 Patient Outcomes 62 CentriMag 62 Non Invasive 62 Coronary Artery 62 Portal Hypertension 62 Parenteral Nutrition 62 pulmonary hypertension PH 62 Aortic Dissection 62 Cell Transplants 62 Nocturia 62 Allograft 62 Thrombocytopenia 62 Vertebral Compression Fracture 62 Randomized Study 62 Heterozygous Familial Hypercholesterolemia 62 Oral Calcitonin 62 Cardiovascular Outcomes 62 Adjuvant Chemotherapy 62 Arterial Disease 62 Trial Evaluating 62 Central Retinal Vein 62 Metastatic Pancreatic Cancer 62 Biliary 62 Clinical Trials Review 62 retinal vein occlusion 62 noninfectious uveitis 62 Nerve Stimulation 62 Statistically Significant 62 Drug Eluting Stents 62 Guidelines Issued 62 Drug Fails 62 PresbyLens ® 62 Decitabine 62 Hypertrophy 62 Decompensated Heart Failure 62 Tumor Targeting 62 Treatment Shows Promise 62 Artery Disease 62 Gastrointestinal GI 62 Neuropathic Pain 62 Subgroup Analysis 62 Sinus Infections 62 invasive candidiasis 62 Androgen Deprivation Therapy 62 Unstable Angina 62 Confirmatory Phase 62 Hormone Receptor Positive 62 Dyslipidemia 62 Transdermal Delivery 62 Novel Oral 62 Generalized Anxiety Disorder 62 malignant ascites 62 Neo Bladder Augment 62 chronic thromboembolic pulmonary 62 Osteoporosis Drugs 62 Chronic Bronchitis 62 Chronic HCV 62 Demonstrates Sustained 62 catheter occlusion 62 Acute Myocardial Infarction AMI 62 Blocked Arteries 62 Skin Lesions 62 diabetic peripheral neuropathy DPN 62 Heel Pain 62 Initiates Phase III 62 Kidney Transplant Patients 62 SHPT 62 CYT# potent vascular disrupting 62 Prostate Cancer Patients 62 Is Well Tolerated 62 Trigeminal Neuralgia 62 Adult Stem Cell Therapy 62 Rilonacept 62 Anticoagulant 62 Chronic Wounds 62 Aortic Aneurysm 62 Emerging Therapies 62 Glucose Monitoring 62 Cervical Dysplasia 62 Pelvic Organ Prolapse 62 Unfractionated Heparin 62 Lung Cancer Survival 62 CoreValve System 62 Invasive Breast Cancer 62 Anti VEGF 62 HER2 Positive 62 Refractory Hodgkin Lymphoma 62 Treating Heart Failure 62 Pemphigus Vulgaris 62 Interferon Alpha 61 Demonstrates Efficacy 61 hyperphenylalaninemia HPA due 61 Prevent Stroke 61 Renal Anemia 61 Platelet Inhibition 61 Renal Disease 61 Preterm Delivery 61 juvenile idiopathic arthritis 61 Valvular Heart Disease 61 Peripheral arterial disease 61 occlusive disease 61 Coronary Angiography 61 Ventricular Assist Devices 61 Lymph Node 61 Breast Density 61 Sjogren Syndrome 61 Randomized Evaluation 61 Cognitive Problems 61 Peritoneal Dialysis 61 Hsp# Inhibitor 61 Bare Metal Stent 61 Ileus 61 Stress Incontinence 61 Chronic Constipation 61 Hepatitis C Genotype 61 Exacerbation 61 Contrast Agents 61 Pneumococcal Vaccine 61 Fibrosis 61 Solid Tumors 61 Advanced Prostate Cancer 61 Embolic 61 Preclinical Data 61 Rotavirus Vaccine 61 Kidney Failure 61 Fibromyalgia Pain 61 Plaque Psoriasis 61 IL# PE#QQR 61 Ventricular Tachycardia 61 Autoimmune Diseases 61 Rheos System 61 Data Suggest 61 Nebulized 61 Test Detects 61 Diabetic Kidney Disease 61 Neoadjuvant Chemotherapy 61 debilitating complication 61 Single Dose 61 Congestive Heart Failure 61 Fewer Side Effects 61 Inhaled Corticosteroids 61 Therapeutic Vaccine 61 Pafuramidine 61 Cervical Spine 61 Shows Efficacy 61 Renal Cell Cancer 61 Study Evaluating 61 Combination Therapy 61 Muscle Wasting 61 systemic fungal infections 61 Fibrin Sealant 61 Endoluminal 61 Percutaneous vertebroplasty 61 Bronchoscopy 61 Hyperlipidemia 61 Hospital Acquired Pneumonia 61 Sipuleucel T 61 Statin Drugs 61 Diagnostic Criteria 61 Radiofrequency Ablation 61 Inhaled Nitric Oxide 61 Successfully Completes Phase 61 Reduces Pain 61 Abrupt discontinuation 61 First Patient Treated 61 Chronic Insomnia 61 AA Amyloidosis 61 Periodontal Disease 61 Soft Tissue 61 Oral Insulin 61 Diabetic Peripheral Neuropathy 61 Initiates Phase 2b 61 Kidney Stones 61 superficial venous 61 Recombinant Human 61 Phase III Pivotal Trial 61 Gene Linked 61 Osteoporosis Treatment 61 either acutely decompensated 61 Major Depressive Disorder 61 Castration Resistant Prostate Cancer 61 Present Preclinical Data 61 saphenous vein graft 61 Alemtuzumab 61 Begins Dosing 61 RNAi Therapeutic 61 Autologous Stem Cell Transplantation 61 Intracranial Aneurysms 61 symptomatic benign prostatic 61 Hyperkalemia 61 Rectal Cancer 61 metastatic malignant 61 Hepatitis C Virus 61 Drug Eluting Stent 61 Autologous 61 Lupus Drug 61 Short Stature 61 Survival Benefit 61 NSAID induced 61 Significantly Reduces 61 Postherpetic Neuralgia 61 undergoing Percutaneous Coronary 61 Oral Spray 61 Claudication 61 Ventricular 61 Phase III Trials 61 Topical Treatment 61 relapsing remitting MS RRMS 61 Systemic Delivery 61 Preclinical Study 61 Elagolix 61 Prostate Cancer Treatment 61 Pain Therapy 61 Bloodstream Infections 61 Aortic Valve 61 Renal Function 61 Prostatic 61 Dual Antiplatelet Therapy 61 artery stenosis 61 Aviptadil 61 FOLOTYN ® 61 Entereg TM 61 Retinopathy 61 Controlled Trial 61 Hemolysis 61 Predict Response 61 Ventricular Arrhythmias 61 Metabolic Endocrinology 61 post herpetic neuralgia PHN 61 treat brain aneurysms 61 severe oral mucositis 61 Chronic Liver Disease 61 CTAP# Capsules 61 secondary hyperparathyroidism 61 Osteoarthritis Patients 61 pouchitis 61 Enzyme Replacement Therapy 61 Radiation Treatment 61 Vertebral Fractures 61 Viral Infection 61 ischemic mitral regurgitation 61 Demonstrates Significant 61 Contrast Agent 61 Combination REOLYSIN R 61 diabetic ulcer 61 Hernia Repair 61 Left Ventricular Hypertrophy 61 Sleep Disturbances 61 Fibromyalgia Syndrome 61 Cerebrospinal Fluid 61 Virus Infection 61 Neovascular AMD 61 refractory gout 61 Tiotropium 61 chronic myocardial ischemia 61 Factor VIIa 61 Myeloma Patients 61 Dendritic Cells 61 Retinal Vein Occlusion 61 Colorectal Screening 61 INTEGRILIN R 61 Cypher Sirolimus 61 Antiplatelet 61 Advanced Heart Failure 61 Personalized Immunotherapy 61 benign prostatic hypertrophy BPH 61 Treatment Regimen 61 Abdominal Pain 61 Paroxysmal Atrial Fibrillation 61 Novel Antibiotic 61 Clinical Efficacy 61 Absorbable 61 Tumor Growth 61 Idiopathic Pulmonary Fibrosis 61 Platelet Rich Plasma 61 Primary Hypercholesterolemia 61 Levels Linked 61 Intraocular 61 immune thrombocytopenic purpura ITP 60 Tissue Engineered 60 Increased Mortality 60 Controlled Study 60 Nicotine Vaccine 60 Phase 2b Study 60 Glucocorticoid 60 Rheumatoid Arthritis 60 Early Diagnosis 60 STARFlex R 60 Radical Prostatectomy 60 Differential Diagnosis 60 Chronic Pelvic Pain 60 Endothelial Dysfunction 60 Therapeutic Potential 60 Mild Cognitive Impairment 60 POSIDUR TM 60 Laryngeal Cancer 60 Dose Ranging Study 60 STRIDE PD 60 Genes Linked 60 myeloid metaplasia 60 Pericardial 60 Prodarsan R 60 Mitomycin C 60 Adjuvant Therapy 60 Synthetic Peptide 60 Skin Structure Infections 60 Cardiovascular Disease Risk 60 Efficacious 60 Angiogenic 60 Atrophic 60 Aortic Stenosis 60 Advanced Renal Cell 60 Anthracycline 60 C Reactive Protein 60 cytomegalovirus infection 60 Bazedoxifene 60 Assist Device 60 Candidiasis 60 Immunotherapeutic 60 Cardiac Resynchronization Therapy 60 Endurant 60 Diabetes Hypertension 60 Urinary tract 60 Robotic Assisted 60 Insulin Pumps 60 Cancer Treatments 60 alpha1 antitrypsin deficiency 60 STELARA TM 60 Study Showed 60 Helps Predict 60 Cocaine Addiction 60 Afib 60 Atrial Flutter 60 osteoporotic vertebral fractures 60 Targeted Therapies 60 Induction Therapy 60 Toxicities 60 Announces FDA Clearance 60 topically administered 60 Invasive Fungal Infections 60 kidney urologic 60 Spasticity 60 Malignancies 60 Ranibizumab 60 Respiratory Distress 60 Ozurdex 60 Bacteremia 60 Radioimmunotherapy 60 Lumbar Spinal Stenosis 60 Critical limb ischemia 60 Pegylated Liposomal Doxorubicin 60 RHEO 60 First Patient Dosed 60 urethral bulking agent 60 Hepatotoxicity 60 Therapy Improves 60 Angiographic 60 Improve Outcomes 60 Therapeutic Effects 60 Uterine Fibroid Embolization 60 Ovarian Cancer Patients 60 anterior uveitis 60 Receives FDA Clearance 60 INS# [001] 60 Bucindolol 60 Long Term Survival 60 hemodialysis peritoneal dialysis 60 Ascites 60 gastrointestinal stromal tumors GIST 60 Hip Fractures 60 Aggressive Prostate Cancer 60 External Beam 60 Angina pectoris 60 Ablation 60 C1 Inhibitor 60 Diuretic 60 atypical hemolytic uremic syndrome 60 SNT-MC#/idebenone 60 Intravesical 60 Antiviral Therapy 60 AFREZZA TM 60 chronic rheumatic 60 Inflammatory Markers 60 Resection 60 Electrophysiology Mapping 60 Pharmacodynamics 60 FDA Clearance 60 Endovascular Treatment 60 riociguat 60 Uterine Fibroids 60 Anti Tumor Activity 60 Hypertriglyceridemia 60 Pegylated Interferon 60 Eculizumab 60 Community Acquired Pneumonia 60 osteoporotic compression fractures 60 Bronchodilator 60 AFRS TM 60 Diabetic Neuropathic Pain 60 Bevacizumab 60 Spinal Fluid 60 Cinquil 60 Lower Extremity 60 KETEK 60 tumor lysis syndrome 60 PROCRIT R 60 Peritoneal 60 Accelerated Partial Breast Irradiation 60 Nonalcoholic Steatohepatitis 60 hoFH 60 Brain Atrophy 60 Diabetic Macular Edema DME 60 knee osteoarthritis OA 60 Chronic Kidney 60 Previously Untreated 60 Oral Cavity 60 Acute Coronary Syndrome 60 See CLINICAL PHARMACOLOGY 60 Cardiogenic Shock 60 treat chronic sinusitis 60 Stomach Cancer 60 neurogenic bladder 60 Preclinical Efficacy 60 Pulmonary Hypertension 60 Progressive Multifocal Leukoencephalopathy 60 Endovascular Repair 60 Systemic Juvenile Idiopathic 60 Nesiritide 60 Glomerular Filtration Rate 60 Premenopausal Women 60 Gene Mutation 60 Blood Clots 60 Showed Significant 60 FASLODEX 60 refractory angina 60 treat benign prostatic 60 Bisphosphonate 60 Obstructive Sleep Apnea 60 LibiGel ® 60 primary immunodeficiency PI 60 Malignancy 60 Female Stress Urinary 60 Leber Hereditary Optic Neuropathy 60 Inflammatory Disease 60 Critically Ill Patients 60 PEGylated interferon beta 1a 60 CLINICAL PHARMACOLOGY 60 peripheral arterial disease 60 CVBT #H 60 acute PAO 60 Demonstrates Potential 60 Lymphatic System 60 cancer neuroendocrine tumor 60 Randomized Controlled Trials 60 Osteomyelitis 60 functional mitral regurgitation 60 Fatty Liver 60 Multiple Myeloma Patients 60 Anastomosis 60 Mitral Valve Repair 60 Monotherapy 60 Endarterectomy 60 IIa Clinical Trial 60 Restenosis 60 Sclerosis 60 Antipsychotic Medications 60 Artificial Pancreas 60 Novel Therapeutic 60 Clinical Study Shows 60 Announces Poster Presentations 60 EECP R 60 Shunts 60 Antipsychotic 60 Cataract Surgery 60 Presents Positive 60 rheumatoid arthritis osteoarthritis ankylosing 60 Image Guided 60 randomized Phase IIb 60 Aurora Kinase 60 Deep Venous Thrombosis 60 Blood Cancers 60 Bosentan 60 Treatment Naive Patients 60 Helicobacter pylori eradication 60 Acute Attacks 60 Proteinuria 60 Oral Anticoagulant 60 Major Depressive Disorder MDD 60 REMINDER ORLive Presents 60 Retreatment 60 Valvular 60 Randomized Phase II 60 Natalizumab 60 Proven Effective 60 Parkinson Disease PD 60 Hematopoietic Stem Cell Transplantation 60 Ranolazine 60 Reperfusion Injury 60 Well Tolerated 60 urolithiasis 60 Fibrinogen 60 post surgical adhesions 60 Insulin Sensitivity 60 thrombocytosis 60 Clinical Evaluation 60 pediatric malignancies 60 Peginterferon 60 Subtypes 60 Eluting Stent 60 Zenvia Phase III 60 Neovascular 60 Keratitis 60 Cognitive Function 60 Expanded Indication 60 TNF alpha antagonist 60 disease GERD 60 Neuroprotection 60 Breast Cancers 60 NIDDM 60 Genetic Markers 60 ACV1 60 diarrhea predominant irritable 60 Lumbar Spine 60 renal denervation 60 Epithelium 60 Significantly Improved 60 Neurodegenerative 60 Prognostic Value 60 Fluorouracil 60 Initiates Dosing 59 Restless Legs Syndrome 59 Treated Patients 59 Progenitor Cell 59 VIVITROL ® 59 SPRIX ® 59 Pulsatile 59 Squalamine 59 Regenerative Cell 59 Brentuximab Vedotin SGN 59 abacavir Ziagen 59 Bendamustine 59 osteoporotic vertebral compression fractures 59 Drug Resistant 59 Therapeutic Antibodies 59 Irritable Bowel 59 Iron Deficiency Anemia 59 Vicriviroc 59 Neovascularization 59 pulmonary alveolar 59 Cleviprex TM clevidipine 59 Cotavance 59 Stent Restenosis 59 Stent Graft 59 Antifungals 59 severe malignant osteopetrosis 59 Bone Fractures 59 Osteoporosis Drug 59 Clinical Validation 59 proliferative diabetic retinopathy 59 Knee Arthritis 59 Erythropoietic 59 recurrent glioma 59 Arthritis Drug 59 Percutaneous Coronary Intervention 59 vitreoretinal disorders 59 Xerostomia 59 ATTR PN 59 Periodontitis 59 AMPLATZER R 59 Randomized Clinical Trials 59 Partial Nephrectomy 59 Dasatinib 59 cystic fibrosis chronic pancreatitis 59 Anticancer Activity 59 cheilitis 59 Tumor Response 59 Intravenous Formulation 59 Atrial Fibrillation AF 59 Phase III Clinical Trials 59 Thiazolidinediones 59 capillary leak 59 Ulcerative Colitis 59 chronic immune thrombocytopenic 59 transthyretin amyloidosis

Back to home page